Eisai's trial success raises hope for Alzheimer's prevention
By Julie SteenhuysenCHICAGO, Sept 30 (Reuters) - Clear evidence this week that Eisai and Biogen's drug lecanemab slows cognitive decline in early stage...
By Julie SteenhuysenCHICAGO, Sept 30 (Reuters) - Clear evidence this week that Eisai and Biogen's drug lecanemab slows cognitive decline in early stage...